← Leaderboards
Robert A Seder
Niaid Extramural Activities
$55,743
Attributed
$55,743
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$55,743 · 1
By mechanism
P51$55,743 · 1
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityVaccinesInfectionT-LymphocyteResponseVaccine DevelopmentProteinsImmuneImmunizationAntibodiesAdjuvantImmune ResponseImmunogenicityVaccinationCd8b1 GeneT Cell ResponseAntigensMalariaMediatingNonhuman PrimateIn VivoAttenuatedCytokineRoute
Grant awards (72)
Development of Pre-Erythrocytic Malaria Vaccines and antibodies$1,663,887
ZIA · FY2025 · AI · contact PI
Cancer Vaccines and Immunotherapy$1,327,187
ZIA · FY2025 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$903,787
ZIA · FY2025 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$1,680,146
ZIA · FY2024 · AI · contact PI
Development of a COVID Vaccine Model in NHP$845,146
ZIA · FY2024 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines and antibodies$422,573
ZIA · FY2024 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$1,056,433
ZIA · FY2023 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines and antibodies$1,056,433
ZIA · FY2023 · AI · contact PI
Development of a COVID Vaccine Model in NHP$332,304
ZIA · FY2023 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines and antibodies$1,584,649
ZIA · FY2022 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$528,216
ZIA · FY2022 · AI · contact PI
Development of a COVID Vaccine Model in NHP$332,304
ZIA · FY2022 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$2,490,549
ZIA · FY2021 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines and antibodies$1,056,433
ZIA · FY2021 · AI · contact PI
Development of a COVID Vaccine Model in NHP$250,000
ZIA · FY2021 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$1,847,416
ZIA · FY2020 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$1,106,483
ZIA · FY2020 · AI · contact PI
Development of a COVID Vaccine Model in NHP$350,000
ZIA · FY2020 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$1,680,701
ZIA · FY2019 · AI · contact PI
Development of Vaccines to Prevent Tuberculosis$1,680,701
ZIA · FY2019 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$3,223,147
ZIA · FY2018 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$1,553,207
ZIA · FY2018 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$5,012,423
ZIA · FY2017 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$2,423,669
ZIA · FY2017 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$2,392,577
ZIA · FY2016 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$1,024,485
ZIA · FY2016 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$4,186,577
ZIA · FY2015 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$524,485
ZIA · FY2015 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$195,037
ZIA · FY2015 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$4,186,577
ZIA · FY2014 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$524,485
ZIA · FY2014 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$195,037
ZIA · FY2014 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$4,186,577
ZIA · FY2013 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$210,038
ZIA · FY2013 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$195,037
ZIA · FY2013 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$4,186,577
ZIA · FY2012 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$210,038
ZIA · FY2012 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$195,037
ZIA · FY2012 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$3,196,577
ZIA · FY2011 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$685,038
ZIA · FY2011 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$685,037
ZIA · FY2011 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$3,205,924
ZIA · FY2010 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$686,986
ZIA · FY2010 · AI · contact PI
Development of Pre-Erythrocytic Malaria Vaccines$686,983
ZIA · FY2010 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$1,641,899
ZIA · FY2009 · AI · contact PI
Factors Regulating T Helper Cell Memory Differentiation$1,641,899
ZIA · FY2009 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$1,641,899
ZIA · FY2009 · AI · contact PI
VACCINE DEVELOPMENT FOR TUBERCULOSIS$55,743
P51 · FY2009 · RR · contact PI
Development Of A Vaccine For Leishmania Major Infection$557,449
Z01 · FY2008 · AI · contact PI
Factors Regulating T Helper Cell Memory Differentiation$557,449
Z01 · FY2008 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$557,449
Z01 · FY2008 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$621,788
Z01 · FY2007 · AI · contact PI
Factors Regulating T Helper Cell Memory Differentiation$621,788
Z01 · FY2007 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$621,788
Z01 · FY2007 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$0
Z01 · FY2006 · AI · contact PI
Factors Regulating T Helper Cell Memory Differentiation$0
Z01 · FY2006 · AI · contact PI
Optimization Of HIV Specific Immune Responses In Vivo$0
Z01 · FY2006 · AI · contact PI
Development Of A Vaccine For Leishmania Major Infection$0
Z01 · FY2005 · AI
Factors Regulating T Helper Cell Memory Differentiation$0
Z01 · FY2005 · AI
Optimization Of HIV Specific Immune Responses In Vivo$0
Z01 · FY2005 · AI
Development Of A Vaccine For Leishmania Major Infection$0
Z01 · FY2004 · AI
Factors Regulating T Helper Cell Memory Differentiation$0
Z01 · FY2004 · AI
Optimization Of HIV Specific Immune Responses In Vivo$0
Z01 · FY2004 · AI
Development Of A Vaccine For Leishmania Major Infection$0
Z01 · FY2003 · AI
Factors Regulating T Helper Cell Memory Differentiation$0
Z01 · FY2003 · AI
Optimization Of HIV Specific Immune Responses In Vivo$0
Z01 · FY2003 · AI
Development Of A Vaccine For Leishmania Major Infection$0
Z01 · FY2002 · AI
Factors Regulating T Helper Cell Memory Differentiation$0
Z01 · FY2002 · AI
Optimization Of Hiv Specific Immune Responses In Vivo$0
Z01 · FY2002 · AI
REGULATION OF CYTOKINE PRODUCTION FROM PATIENTS INFECTED W/HIV &TB$0
Z01 · FY2000 · AI
DNA VACCINATION FOR PREVENTION OF VIRAL, PARASITIC AND MYCOBACTERIAL INFECTION$0
Z01 · FY2000 · AI
CYTOKINE REGULATION IN ANIMALS INFECTED WITH HISTOPLASMA CAPSULATUM$0
Z01 · FY2000 · AI